From Cost Containment to Care Strategy | Live Webinar + Q&A Wednesday, June 17 | 1 PM ET / 10 AM PT Cody Fair, Chief Commercial Officer, Noom Health, Jennifer A Jones, Head of Clinical Solutions, Noom Health, and Kembre Roberts, PhD, SVP Health Solutions, AON will cover: Why GLP-1 utilization is increasing How restriction strategies without a behavior component often shift costs rather than reduce them What our member data shows about persistence and behavioral support for durable outcomes If GLP-1 spend is on your benefits agenda this year and for most teams, it is you won't want to miss this
Pediatr Radiol 43(10):14091410
Historically, BB is known for its role as the last biosynthetic intermediate in a series of endogenous reactions used to synthesize l-carnitine from lysine (38)
Your treatment plan includes baseline mood assessment, regular check-in calls to monitor mental health alongside weight loss, and access to PlexusDx's clinical team
PMID 24368434
For many patients, an initial video visit confirms the provider is real, qualified, and reachable, while ongoing check-ins keep care from feeling like a prescription on autopilot